Dager WE - Search Results

1

Low-molecular-weight heparins in renal impairment and obesity: available evidence and clinical practice recommendations across medical and surgical settings.

Nutescu EA, Spinler SA, Wittkowsky A, Dager WE. Nutescu EA, et al. Among authors: dager we. Ann Pharmacother. 2009 Jun;43(6):1064-83. doi: 10.1345/aph.1L194. Epub 2009 May 19. Ann Pharmacother. 2009. PMID: 19458109 Review.

2

Argatroban for heparin-induced thrombocytopenia in hepato-renal failure and CVVHD.

Dager WE, White RH. Dager WE, et al. Ann Pharmacother. 2003 Sep;37(9):1232-6. doi: 10.1345/aph.1D010. Ann Pharmacother. 2003. PMID: 12921505

3

Overview of heparin-induced thrombocytopenia.

Spinler SA, Dager W. Spinler SA, et al. Am J Health Syst Pharm. 2003 Oct 15;60 Suppl 5:S5-11. doi: 10.1093/ajhp/60.suppl_5.S5. Am J Health Syst Pharm. 2003. PMID: 14593977 Review.

4

Key articles and guidelines relative to treatment of patients with acute coronary syndromes.

Dobesh PP, Brouse SD, Johnson DC, Dager WE, Bell D, Daly DE, Olin JL, Wodlinger AM. Dobesh PP, et al. Among authors: dager we. Pharmacotherapy. 2004 Jan;24(1):105-44. doi: 10.1592/phco.24.1.105.34811. Pharmacotherapy. 2004. PMID: 14740792

5

Low-molecular-weight heparin-induced thrombocytopenia in a child.

Dager WE, White RH. Dager WE, et al. Ann Pharmacother. 2004 Feb;38(2):247-50. doi: 10.1345/aph.1D308. Epub 2003 Dec 23. Ann Pharmacother. 2004. PMID: 14742760

6

Special considerations with fondaparinux therapy: heparin-induced thrombocytopenia and wound healing.

Dager WE, Andersen J, Nutescu E. Dager WE, et al. Pharmacotherapy. 2004 Jul;24(7 Pt 2):88S-94S. doi: 10.1592/phco.24.10.88s.36122. Pharmacotherapy. 2004. PMID: 15317404 Review.

7

Ximelagatran: an oral direct thrombin inhibitor.

Dager WE, Vondracek TG, McIntosh BA, Nutescu EA. Dager WE, et al. Ann Pharmacother. 2004 Nov;38(11):1881-97. doi: 10.1345/aph.1E078. Epub 2004 Sep 21. Ann Pharmacother. 2004. PMID: 15383641 Review.

8

Transitioning from traditional to novel anticoagulants: the impact of oral direct thrombin inhibitors on anticoagulation management.

Nutescu EA, Spinler SA, Dager WE, Bussey HI. Nutescu EA, et al. Among authors: dager we. Pharmacotherapy. 2004 Oct;24(10 Pt 2):199S-202S. doi: 10.1592/phco.24.15.199s.43159. Pharmacotherapy. 2004. PMID: 15624340

9

Tinzaparin in outpatients with pulmonary embolism or deep vein thrombosis.

Dager WE, King JH, Branch JM, Chow SL, Ferrer RE, Pak S, Togioka PY, White RH. Dager WE, et al. Ann Pharmacother. 2005 Jul-Aug;39(7-8):1182-7. doi: 10.1345/aph.1E677. Epub 2005 Jun 14. Ann Pharmacother. 2005. PMID: 15956232

10

Uncertain times for oral anticoagulation therapy.

Nutescu EA, Wittkowsky AK, Dager WE. Nutescu EA, et al. Among authors: dager we. Am J Health Syst Pharm. 2005 Jul 15;62(14):1449. doi: 10.2146/ajhp050015. Am J Health Syst Pharm. 2005. PMID: 15998924 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

108 results

Search Page